n-formylmethionyl-methionyl-phenylalanine has been researched along with Coronary Disease in 1 studies
*Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buko, IV; Cherenkevich, SN; Gorudko, IV; Konstantinova, EE; Kostevich, VA; Panasenko, OM; Shamova, EV; Sokolov, AV; Vasiliev, VB | 1 |
1 other study(ies) available for n-formylmethionyl-methionyl-phenylalanine and Coronary Disease
| Article | Year |
|---|---|
Functional activity of neutrophils in diabetes mellitus and coronary heart disease: role of myeloperoxidase in the development of oxidative stress.
Topics: Catalase; Coronary Disease; Diabetes Mellitus, Type 2; Enzyme Activation; Glutathione; Humans; Hydrogen Peroxide; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxidative Stress; Peroxidase; Reactive Oxygen Species | 2012 |